COMUNICADO: Results From the First and Largest Collaborative Study Confirm Role of Enbrel(R) in Psoriatic Arthritis (y 2)

 

COMUNICADO: Results From the First and Largest Collaborative Study Confirm Role of Enbrel(R) in Psoriatic Arthritis (y 2)

Actualizado 04/12/2008 12:03:20 CET


REFERENCES
(1) Poster P29 from the Gene to Clinic meeting, December 2008. Sterry. W.
et al. Results of a Randomized, Double-Blind Study to Evaluate the
Efficacy and Safety of Etanercept in Patients with Psoriasis and
Psoriatic Arthritis: The PRESTA Trial
(2) Richards HL et al. The contribution of perceptions of stigmatization
to disability in patients with psoriasis. J Psychosom Res.
2001;50:11-15.
(3) Poster P30 from the Gene to Clinic meeting, December 2008. Barker, J.
et all. Improvement in the Dermatology Life Quality Index for
Patients With Psoriasis and Psoriatic Arthritis Treated with
Etanercept

For further information, please contact: Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct Tel: +44-1628-692536, Email: markhagl@wyeth.com; Danielle Halstrom, Communications - Global, Direct Tel: +1-484-865-2020, Email: halstrd@wyeth.com; OgilvyHealthPR: Mary Barrington-Ward, Tel: +44-207-108-6066, Email: mary.barrington-ward@ohpr.com; Nerea Hinzpeter, Tel: +1-212-625-4178, Email: Nerea.hinzpeter@ohpr.com

Mejora la comunicación de tu empresa con Europa Press Comunicación

Mejora la comunicación de tu empresa con Europa Press Comunicación

Esta web utiliza cookies propias y de terceros para analizar su navegación y ofrecerle un servicio más personalizado y publicidad acorde a sus intereses. Continuar navegando implica la aceptación de nuestra política de cookies -
Uso de cookies